Literature DB >> 1394429

Molecular basis of human hypertension: role of angiotensinogen.

X Jeunemaitre1, F Soubrier, Y V Kotelevtsev, R P Lifton, C S Williams, A Charru, S C Hunt, P N Hopkins, R R Williams, J M Lalouel.   

Abstract

Essential hypertension is a common human disease believed to result from the interplay of multiple genetic and environmental determinants. In genetic studies of two large panels of hypertensive sibships from widely separated geographical areas, we obtained evidence of genetic linkage between the angiotensinogen gene (AGT) and hypertension, demonstrated association of AGT molecular variants with the disease, and found significant differences in plasma concentrations of angiotensinogen among hypertensive subjects with different AGT genotypes. The corroboration and replication afforded by these results support the interpretation that molecular variants of AGT constitute inherited predispositions to essential hypertension in humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394429     DOI: 10.1016/0092-8674(92)90275-h

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  303 in total

1.  Fluxes and metabolic pools as model traits for quantitative genetics. I. The L-shaped distribution of gene effects.

Authors:  B Bost; C Dillmann; D de Vienne
Journal:  Genetics       Date:  1999-12       Impact factor: 4.562

2.  A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

Authors:  S Cheng; M A Grow; C Pallaud; W Klitz; H A Erlich; S Visvikis; J J Chen; C R Pullinger; M J Malloy; G Siest; J P Kane
Journal:  Genome Res       Date:  1999-10       Impact factor: 9.043

3.  Identification of candidate coding region single nucleotide polymorphisms in 165 human genes using assembled expressed sequence tags.

Authors:  K Garg; P Green; D A Nickerson
Journal:  Genome Res       Date:  1999-11       Impact factor: 9.043

Review 4.  Investigation of hypertension and the recognition of monogenic hypertension.

Authors:  D V Milford
Journal:  Arch Dis Child       Date:  1999-11       Impact factor: 3.791

Review 5.  Current genetics of essential hypertension.

Authors:  T Katsuya; T Ogihara
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

Review 6.  Angiotensin I-converting enzyme: genotype and disease associations.

Authors:  D Crisan; J Carr
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

Review 7.  Designing antisense to inhibit the renin-angiotensin system.

Authors:  D Mohuczy; M I Phillips
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

8.  Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease.

Authors:  P R Elliott; X Y Pei; T R Dafforn; D A Lomas
Journal:  Protein Sci       Date:  2000-07       Impact factor: 6.725

Review 9.  Genetic determinants of vascular reactivity.

Authors:  Daniel Henrion; Joelle Benessiano; Marc Iglarz; Ivan Philip; Bernard I Levy
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

10.  Review of "angiotensin genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II".

Authors:  N J Schork
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.